Intelligence · Clinical Pipeline
Infectious disease · Phase I
Infectious disease programs at Phase I — ClinicalTrials.gov pipeline intelligence.
- Programs
- 240
Quick answer
Infectious disease Phase I programs: NovaPharmaNews indexes 240 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- United Therapeutics Europe 23 programs
- ENANTA PHARMACEUTICALS 14 programs
- Vertex Pharmaceuticals (Australia) 11 programs
- BRIGHT MINDS BIOSCIENCES 10 programs
- Chinese Academy of 10 programs
- ASSEMBLY BIOSCIENCES 9 programs
- Anaxis Pharma 9 programs
- Aligos Therapeutics 8 programs
- Sunshine Guojian Pharmaceutical 8 programs
- INOVIO Pharmaceuticals 7 programs
- MSD Merck Sharp 6 programs
- Sinovac Research and 6 programs
-
SOF/VEL/VOX
Gilead Sciences Ireland UC
HCV Infection
1 trial -
Safety Assessment of 10-Day Daily Bucco-Oral Administration of Transfer Factor in Healthy Adult Human Subjects
s.r.o.
healthy subjects, It is used in conditions with decreased immunity to enhance it e.g. in case of recurrent and chronic viral infections.
1 trial -
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AB-101 Following Oral Administration in Healthy and Chronic Hepatitis B Subjects
Arbutus Biopharma Corp
Chronic hepatitis B virus Infection
1 trial -
Sinovac PCV24 formulation 1
Sinovac Research and Development Co.,
Pneumococcal Infectious Disease
2 trials -
Sotrovimab
Vir Biotechnology
COVID-19 Infection
1 trial -
Sporozoite Challenge Model for Plasmodium vivax in Humans
BRIGHT MINDS BIOSCIENCES INC.
Malaria, Vivax
1 trial -
Sulopenem
Iterum Therapeutics plc
Urinary Tract Infections
1 trial -
TAF/EVG Vaginal Insert
United Therapeutics Europe Ltd
Hiv
1 trial -
TD-1607
Theravance Biopharma Ireland Umited
Serious Infections Due to Known or Suspected Gram-positive Pathogens
1 trial -
TD-1607
Theravance Biopharma Ireland Umited
Infections
1 trial -
TD-6450
Theravance Biopharma Ireland Umited
Hepatitis C
2 trials -
TI-0010
BRIGHT MINDS BIOSCIENCES INC.
COVID-19
1 trial -
TKM-100201
Arbutus Biopharma Corp
Ebola Virus Infection
1 trial -
TKM-100802 for Injection
Arbutus Biopharma Corp
Ebola Virus Infection
1 trial -
TNP-2092 capsules
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
1 trial -
TVB-2640 - 50 mg
Sagimet Biosciences
Non-alcoholic Steatohepatitis
1 trial -
Telaprevir; Moxifloxacin; Placebo
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
1 trial -
The pivotal bioequivalence study comparing the test product to the reference product, which belong to the group of medicines used in treatment of uncomplicated lower urinary tract infections.
Sciencepharma Sp. z o.o
Not applicable (submitted trial is a bioequivalence in healthy subjects)
1 trial -
Treatment of Respiratory Complications Associated with COVID-19, Influenza A, Metapneumovirus, Respiratory Syncytial Virus (RSV) Infection Using Wharton’s Jelly (WJ)-Umbilical Cord (UC) Mesenchymal Stromal Cells (ProTrans®): open Phase IB Clinical Trial
Lacuna Pharma Pty Ltd
Respiratory viral disease, COVID-19, Influenza A, Metapneumovirus, Respiratory syncytial virus Infection
1 trial -
Treatment sequence AB
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
1 trial -
Two doses of middle-dose recombinant SARS-CoV-2 vaccine (Sf9 Cell) at the schedule of day 0, 28
Jiangsu Province Centers for Disease Control and Prevention
COVID-19
1 trial -
UB-421 SC
United Therapeutics Europe Ltd
HIV-1-infection
1 trial -
UB-421 SC(dB4C7C22-6 mAb)
United Therapeutics Europe Ltd
HIV-1 Infection
1 trial -
UB-621
United Therapeutics Europe Ltd
Herpes Simplex Virus Infection
1 trial -
VCH 916
Vertex Pharmaceuticals (Australia) Pty.
HCV Infection
1 trial -
VCH-222
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
1 trial -
VGX-3100
INOVIO PHARMACEUTICALS, INC.
Papillomavirus Infections
1 trial -
VGX-6150
INOVIO PHARMACEUTICALS, INC.
Hepatitis C, Chronic
1 trial -
VIR-1111
Vir Biotechnology
HIV I Infection
1 trial -
VIR-3434
Vir Biotechnology
Chronic Hepatitis B
1 trial -
VRON-0200-AdC6
Vir Biotechnology
Chronic Hepatitis B
1 trial -
VX-985 or matching placebo
Vertex Pharmaceuticals (Australia) Pty.
Chronic Hepatitis C
1 trial -
Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg
Hospital Authority, Hong Kong
COVID-19 Pandemic
1 trial -
Vebicorvir (VBR)
ASSEMBLY BIOSCIENCES, INC.
Chronic Hepatitis B
1 trial -
Virus-specific T-cell Immunity for the Treatment of Some Resistant Viral Infections After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Istituto Gentili S.r.l.
Patients who have received an allogeneic haematopoietic stem cell transplant and who have developed post-transplant viral reactivation (CMV, Adenovirus, EBV) resistant to pharmacological therapies.
1 trial -
Woman-focused intervention
BRIGHT MINDS BIOSCIENCES INC.
HIV
1 trial -
XTL 6865
XTL BIOPHARMACEUTICALS LTD
Hepatitis C
1 trial -
XTL-2125
XTL BIOPHARMACEUTICALS LTD
Chronic Hepatitis C Virus Infection
1 trial -
Yinhu Qingwen Granules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Viral Pneumonia
1 trial -
ZFN modified T cells
SANGAMO THERAPEUTICS, INC
HIV
1 trial -
intraconazole
ENANTA PHARMACEUTICALS INC
NASH - Nonalcoholic Steatohepatitis
1 trial -
randomized, double-blinded, placebo-controlled
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Prevention of COVID-19 Caused by SARS-CoV-2
1 trial -
routine HIV testing
BRIGHT MINDS BIOSCIENCES INC.
HIV Infections
1 trial -
sD-NP-GT8 DNA
INOVIO PHARMACEUTICALS, INC.
HIV Infections
1 trial -
shenhuang granule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sepsis
1 trial -
telaprevir formulation A
Vertex Pharmaceuticals (Australia) Pty.
Chronic Hepatitis C
1 trial -
yimitasvir
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Chronic Hepatitis c
1 trial -
zelicapavir (therapeutic dose)
ENANTA PHARMACEUTICALS INC
RSV Infection
1 trial
Frequently asked questions
How many infectious disease Phase I programs exist?
240 programs match both the therapeutic area and stage filters in our published index.
Data attribution: Data sources · All pipeline programs